|
Biotechnology and its social and economic implications have
been hotly debated in the pages of the popular press from The Wall Street Journal
to Time Magazine, as well as on the nightly news. In fact, according to
Richard W. Oliver, biotech and its commercial applications -- bioterials -- will
surpass the Information Age as the new engine of the economy. "By the middle
of the 21st century, all companies will be bioterial companies," predicts
Oliver. "The bioterials economy will grow faster, be more global, more pervasive
and more powerful than any model before it." An
essential discussion to the future of business, The Coming Biotech Age
describes the biotech revolution taking place within our leading universities,
corporations and government. Without daunting scientific jargon, Oliver reveals
what everyone -- CEOs, investors, policymakers and others interested in the social
ramifications of bioterials -- must know, for instance: - How
the biotech lab is becoming a Gene-Factory -- with the mass production
of healthcare, agricultural, and commercial/industrial products
- How
the Bioterial Age will fundamentally alter the laws of economics as we know them
- How
biotechnology will eliminate aging and disease
Oliver
also takes a look at the biovisionaries -- researchers, scientists and business
leaders -- behind the biotech movement, and the biocapitalists who are poised
to cash in on the new era. A unique focus on The Coming
Biotech Age is the positive effect that biotech will have on the global economy.
For instance, global chemical suppliers (DuPont, Novatis, Monsanto) are reinventing
themselves as biotech firms, joining over 4000 biotechnology organizations around
the world creating new jobs and new products. While Oliver does discuss potential
dangers of biotechnologies, he also points out the tremendous advances biotech
has brought: - Over 100 million people worldwide
have been helped by the development of new biotechnology products and vaccines.
- Hundreds
of biotechnology products and vaccines are currently in human clinical trials
and hundreds more are in early development
In
The Coming Biotech Age you'll read about these remarkable bioterial developments:
pharmaceuticals tailored to an individual's genetic makeup... babies made healthy
through genetic modification... pest- and disease-resistant food... "smart"
materials that mimic human processes... endless solar energy machines... and many
more. Oliver places these developments within an economic context, explaining
what these advances will mean to the global business community. The
potential for bioterials is tremendous -- and infinite. If you're in business
you cannot afford to miss The Coming Biotech Age. Truly, your company's
future will depend on it. Richard W. Oliver is a professor
at the Owen Graduate School of Management at Vanderbilt University in Nashville,
Tennessee. He was previously Vice President of Marketing at Nortel and a marketing
executive at DuPont. Dr. Oliver serves on the Boards of Directors of six U.S.
companies and consults to organizations around the world. His previous books are
The Shape of Things to Come: 7 Imperatives for Winning in the New World of
Business and The Eagle and the Monk: 7 Principles of Successful Change.
| 
